Control Print Limited is the fourth Indian mask manufacturer since the Covid- 19 outbreak in 2020 to receive the USFDA 510(k) authorisation, one of the most rigorous regulatory compliances and globally accepted certification for surgical masks. The 510(k) certification endows The Mask Lab, a venture by Control Print Limited, the marketing authorisation needed to supply the US healthcare and business community, including the public, with the world's highest quality medical-grade 3 Ply surgical masks to protect from the transfer of microorganisms, body fluids and particulate material. The USFDA 510(k), BIS, CE, and ISO 13485 certifications establish that The Mask Lab's products are safe and effective for human use after extensive third-party testing for engineering performance, sterility, safety, and biocompatibility, attaining legal approval for commercial distribution worldwide.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
913 INR | -0.92% | -2.68% | -8.80% |
04-04 | Control Print Limited Announces Cessation of Shyam Sunder Jangid and Gaurav Himatsingka as Independent Directors | CI |
03-27 | Control Print Limited Approves Board Appointments | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.80% | 175M | |
+12.96% | 84.57B | |
+16.38% | 68.85B | |
+12.13% | 34.99B | |
+19.98% | 33.27B | |
+12.78% | 28.93B | |
+3.33% | 26.78B | |
+0.73% | 25.51B | |
+13.59% | 24.82B | |
+16.37% | 24.6B |
- Stock Market
- Equities
- CONTROLPR Stock
- News Control Print Limited
- Control Print Limited Receives USFDA 510(K) Clearance for Commercial Distribution of 3 Ply Surgical Masks in the United States